
|Articles|August 20, 2014
The Medical Innovation Threat
Advertisement
An invasive species has been introduced into the U.S. health innovation ecosystem, with a growing danger of permanent damage to the development of specialty drugs. The relentless assault on the price of Sovaldi is becoming a threat to the 30-year political balance that has energized the biomedical revolution.
Source: The Wall Street Journal
Read the full story:
Advertisement
Related Content
Advertisement


MRI Shows Hypothalamic Atrophy in Narcolepsy Type 1, Sparing Subregion
Published: | Updated:



Advertisement
Advertisement
Trending on AJMC
1
FDA Expands Tirzepatide Label to Reduce Cardiovascular Risk in Type 2 Diabetes
2
Unvaccinated COVID-19 Infection Tied to Higher Myocarditis Risk
3
DOJ Abandons Olmstead Defense as Texas v Kennedy Advances
4
FDA Approves Rusfertide to Treat Erythrocytosis In Polycythemia Vera
5
